The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scottish Intercollegiate Guidelines Network
Twaddle, S., & Qureshi, S. (2005) · Evidence-based Healthcare and Public Health · doi:10.1016/j.ehbc.2005.09.008 · Cited by 4,084
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Clarke, R., Peden, J. F., Hopewell, J. C., Kyriakou, T., Goel, A., Heath, S. C., Parish, S., Barlera, S., Franzosi, M. G., Rust, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902604 · Cited by 1,671
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481
Smolen, J. S., Beaulieu, A., Rubbert-Roth, A., Ramos-Remus, C., Rovensky, J., Alecock, E., Woodworth, T., & Alten, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60453-5 · Cited by 1,399
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2998 · Cited by 1,331
Peters, M. J. L., Symmons, D. P. M., McCarey, D., Dijkmans, B. A. C., Nicola, P., Kvien, T. K., McInnes, I. B., Haentzschel, H., Gonzalez-Gay, M. A., Provan, S., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.113696 · Cited by 1,325
Self-citation(2012) · The Lancet · doi:10.1016/s0140-6736(12)60110-x · Cited by 1,146
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Fleischmann, R., Kremer, J., Cush, J., Schulze-Koops, H., Connell, C. A., Bradley, J. D., Gruben, D., Wallenstein, G. V., Zwillich, S. H., & Kanik, K. S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109071 · Cited by 1,024
Drozdzowska, B., Pluskiewicz, W., Halaba, Z. P., Misiołek, H., & Beck, B. R. (2005) · Cited by 984
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
van Vollenhoven, R. F., Fleischmann, R., Cohen, S., Lee, E. B., García Meijide, J. A., Wagner, S., Forejtova, S., Zwillich, S. H., Gruben, D., Koncz, T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112072 · Cited by 945
Avina-Zubieta, J. A., Thomas, J., Sadatsafavi, M., Lehman, A. J., & Lacaille, D. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200726 · Cited by 945
Genovese, M. C., McKay, J. D., Nasonov, E. L., Mysler, E. F., da Silva, N. A., Alecock, E., Woodworth, T., & Gomez‐Reino, J. J. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23940 · Cited by 855
(2012) · The Lancet · doi:10.1016/s0140-6736(11)61931-4 · Cited by 823
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
Sandborn, W. J., Ghosh, S., Panes, J., Vranic, I., Su, C., Rousell, S., & Niezychowski, W. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112168 · Cited by 800
Jones, G., Sebba, A., Gu, J., Lowenstein, M. B., Calvo, A., Gomez-Reino, J. J., Siri, D. A., Tomšič, M., Alecock, E., Woodworth, T., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.105197 · Cited by 797
Maini, R. N., Taylor, P. C., Szechinski, J., Pavelka, K., Bröll, J., Balint, G., Emery, P., Raemen, F., Petersen, J., Smolen, J., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22033 · Cited by 790
Liu, Y., Coresh, J., Eustace, J. A., Longenecker, J. C., Jaar, B., Fink, N. E., Tracy, R. P., Powe, N. R., & Klag, M. J. (2004) · JAMA · doi:10.1001/jama.291.4.451 · Cited by 777
Amarenco, P., Labreuche, J., Lavallée, P., & Touboul, P.-J. (2004) · Stroke · doi:10.1161/01.str.0000147965.52712.fa · Cited by 746
Nishimoto, N., Hashimoto, J., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Murata, N., van der Heijde, D., & Kishimoto, T. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.068064 · Cited by 727
Gabay, C., Emery, P., van Vollenhoven, R., Dikranian, A., Alten, R., Pavelka, K., Klearman, M., Musselman, D., Agarwal, S., Green, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60250-0 · Cited by 672
Myasoedova, E., Crowson, C. S., Kremers, H. M., Roger, V. L., Fitz-Gibbon, P. D., Therneau, T. M., & Gabriel, S. E. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.135871 · Cited by 586
Dixon, W. G., Watson, K. D., Lunt, M., Hyrich, K. L., Silman, A. J., & Symmons, D. P. M. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22809 · Cited by 562
Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress
Kontush, A., Chantepie, S., & Chapman, M. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000091338.93223.e8 · Cited by 452
Meune, C., Touze, E., Trinquart, L., & Allanore, Y. (2009) · Rheumatology · doi:10.1093/rheumatology/kep252 · Cited by 431
Kremer, J. M., Cohen, S., Wilkinson, B. E., Connell, C. A., French, J. L., Gomez‐Reino, J., Gruben, D., Kanik, K. S., Krishnaswami, S., Pascual‐Ramos, V., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33419 · Cited by 344
Boers, M., Nurmohamed, M. T., Doelman, C. J. A., Lard, L. R., Verhoeven, A. C., Voskuyl, A. E., Huizinga, T. W. J., van de Stadt, R. J., Dijkmans, B. A. C., & van der Linden, S. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.9.842 · Cited by 283
Lipid profiles in untreated patients with rheumatoid arthritis.
Park, Y., Lee, S. K., Lee, W. K., Suh, C., Lee, C. W., Lee, C. H., Song, C. H., & Lee, J. (1999) · PubMed · Cited by 252
British Society for Rheumatology Biologics Register
Silman, A. J., Symmons, D. P. M., Scott, D. G. I., & Griffiths, I. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.suppl_2.ii28 · Cited by 248
Georgiadis, A. N., Papavasiliou, E. C., Lourida, E. S., Alamanos, Y., Kostara, C., Tselepis, A. D., & Drosos, A. A. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1952 · Cited by 247
van Halm, V. P., Nielen, M. M. J., Nurmohamed, M. T., van Schaardenburg, D., Reesink, H. W., Voskuyl, A. E., Twisk, J. W. R., van de Stadt, R. J., de Koning, M. H. M. T., Habibuw, M. R., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.051672 · Cited by 231
Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis
Jacobsson, L. T. H., Turesson, C., Nilsson, J.-Å., Petersson, I. F., Lindqvist, E., Saxne, T., & Geborek, P. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062497 · Cited by 229
Singh, J. A., & Strand, V (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.081604 · Cited by 226
Charles-Schoeman, C., Lee, Y. Y., Grijalva, V., Amjadi, S., FitzGerald, J., Ranganath, V. K., Taylor, M., McMahon, M., Paulus, H. E., & Reddy, S. T. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200493 · Cited by 222
Total cholesterol and LDL levels decrease before rheumatoid arthritis
Myasoedova, E., Crowson, C. S., Kremers, H. M., Fitz-Gibbon, P. D., Therneau, T. M., & Gabriel, S. E. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.122374 · Cited by 203
Tam, L.-S., Tomlinson, B., Chu, T. T., Li, T. K., & Li, E. K. (2007) · Clinical Rheumatology · doi:10.1007/s10067-007-0539-8 · Cited by 197
Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells.
Ettinger, W. H., Varma, V. K., Sorci-Thomas, M., Parks, J. S., Sigmon, R. C., Smith, T. K., & Verdery, R. B. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.8 · Cited by 195
Meta-analysis of Observational Studies
Greenwood, D. C. (2012) · Modern Methods for Epidemiology · doi:10.1007/978-94-007-3024-3_10 · Cited by 179
Park, Y.-B., Choi, H. K., Kim, M.-Y., Lee, W.-K., Song, J., Kim, D.-K., & Lee, S.-K. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01186-5 · Cited by 176
Daïen, C. I., Duny, Y., Barnetche, T., Daurès, J.-P., Combe, B., & Morel, J. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201148 · Cited by 171
Reiss, A. B., Carsons, S. E., Anwar, K., Rao, S., Edelman, S. D., Zhang, H., Fernandez, P., Cronstein, B. N., & Chan, E. S. L. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24040 · Cited by 168
Popa, C. D., van den Hoogen, F. H. J., Radstake, T. R. D. J., Netea, M. G., Eijsbouts, A. M. M., den Heijer, M., van der Meer, J. W. M., van Riel, P. L. C. M., Stalenhoef, A. F. H., & Barrera, P. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.066191 · Cited by 167
Yazıcı, Y., Curtis, J. R., Ince, A., Baraf, H. S. B., Malamet, R., Teng, L. L., & Kavanaugh, A. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.148700 · Cited by 165
Burmester, G. R., Feist, E., Kellner, H., Braun, J., Iking-Konert, C., & Rubbert-Roth, A. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.139725 · Cited by 164
Watanabe, J., Charles‐Schoeman, C., Miao, Y., Elashoff, D., Lee, Y. Y., Katselis, G., Lee, T. D., & Reddy, S. T. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34363 · Cited by 161
Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk
Barter, P. J., & Rye, K.-A. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r024075 · Cited by 158
Dursunoğlu, D., Evrengül, H., Polat, B., et al. (2004) · Rheumatology International · doi:10.1007/s00296-004-0438-0 · Cited by 152
Changes in the concentration and composition of plasma lipoproteins during the acute phase response
Carpentier, Y. A., & Scruel, O. (2002) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200203000-00006 · Cited by 148
Morris, S. J., Wasko, M. C., Antohe, J. L., Sartorius, J. A., Kirchner, H. L., Dancea, S., & Bili, A. (2010) · Arthritis Care & Research · doi:10.1002/acr.20393 · Cited by 144
Brown, W. V. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.08.003 · Cited by 143
Navarro-Millán, I. Y., Charles‐Schoeman, C., Yang, S., Bathon, J. M., Bridges, S. L., Chen, L., Cofield, S. S., Dell’Italia, L. J., Moreland, L. W., O’Dell, J. R., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37916 · Cited by 139
deLemos, A. S., Wolfe, M. L., Long, C., Sivapackianathan, R., & Rader, D. J. (2002) · Circulation · doi:10.1161/01.cir.0000028423.07623.6a · Cited by 138
Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis
Munro, R., Morrison, E., McDonald, A. G., Hunter, J. A., Madhok, R., & Capell, H. A. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.6.374 · Cited by 137
Kerekes, G., Soltész, P., Dér, H., Veres, K., Szabó, Z., Végvári, A., Szegedi, G., Shoenfeld, Y., & Szekanecz, Z. (2009) · Clinical Rheumatology · doi:10.1007/s10067-009-1095-1 · Cited by 128
Sattar, N. A., Crompton, P., Cherry, L., Kane, D., Lowe, G. D. O., & McInnes, I. B. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22447 · Cited by 128
Self-citationPopa, C. D., van Tits, L. J. H., Barrera, P., Lemmers, H., van den Hoogen, F. H. J., van Riel, P. L. C. M., Radstake, T. R. D. J., Netea, M. G., Roest, M., & Stalenhoef, A. F. H. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092171 · Cited by 128
Atherogenic effects of TNF-α and IL-6 via up-regulation of scavenger receptors
Hashizume, M., & Mihara, M. (2012) · Cytokine · doi:10.1016/j.cyto.2012.02.010 · Cited by 116
van Eijk, I. C., de Vries, M. K., Levels, J. H. M., Peters, M. J. L., Huizer, E. E., Dijkmans, B. A. C., van der Horst-Bruinsma, I. E., Hazenberg, B. P. C., van de Stadt, R. J., Wolbink, G., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24492 · Cited by 112
Self-citationThe Effect of TNF-alpha Blocking Therapy on Lipid Levels in Rheumatoid Arthritis: A Meta-Analysis
van Sijl, A. M., Peters, M. J. L., Knol, D. L., de Vet, R. H. C., Sattar, N. A., Dijkmans, B. A. C., Smulders, Y. M., & Nurmohamed, M. T. (2011) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2011.04.003 · Cited by 101
Self-citationYamanaka, H., Tanaka, Y., Inoue, E., Hoshi, D., Momohara, S., Hanami, K., Yunoue, N., Saito, K., Amano, K., Kameda, H., et al. (2010) · Modern Rheumatology · doi:10.1007/s10165-010-0366-7 · Cited by 93
Serum total, HDL, LDL cholesterol, and triglyceride levels in patients with rheumatoid arthritis
Lakatos, J., & Hárságyi, Á. (1988) · Clinical Biochemistry · doi:10.1016/s0009-9120(88)80094-8 · Cited by 80
Raterman, H. G., Levels, H., Voskuyl, A. E., Lems, W. F., Dijkmans, B. A. C., & Nurmohamed, M. T. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201228 · Cited by 80
Allanore, Y., Kahan, A., Sellam, J., Ekindjian, O. G., & Borderie, D. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.08.010 · Cited by 77
Yoo, W. (2004) · PubMed · Cited by 69
Yamanaka, H., Tanaka, Y., Inoue, E., Hoshi, D., Momohara, S., Hanami, K., Yunoue, N., Saito, K., Amano, K., Kameda, H., et al. (2011) · Modern Rheumatology · doi:10.3109/s10165-010-0366-7 · Cited by 59
Peters, M. J. L., Voskuyl, A. E., Sattar, N. A., Dijkmans, B. A. C., Smulders, Y. M., & Nurmohamed, M. T. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02220.x · Cited by 57
Self-citationChung, C. P., Oeser, A. M., Raggi, P., Sokka, T., Pincus, T., Solus, J. F., Linton, M. F., Fazio, S., & Stein, C. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.090639 · Cited by 54
Arts, E., Fransen, J., Lemmers, H., Stalenhoef, A. F. H., Joosten, L. A. B., van Riel, P. L. C. M., & Popa, C. D. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3842 · Cited by 45
Dyslipoproteinaemia in a subset of patients with rheumatoid arthritis.
Kavanaugh, A. (1994) · Annals of the Rheumatic Diseases · doi:10.1136/ard.53.8.551 · Cited by 30
Campana, C., & Oliva, F. (2014) · Giornale italiano di cardiologia · doi:10.1714/1394.15512 · Cited by 1
Komuro (2001) · doi:10.1002/1529-0131(200112)44:12
Cited by
Pathogenetic insights from the treatment of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31472-1 · Cited by 1,345
Self-citationImmunopathogenesis of Rheumatoid Arthritis
Firestein, G. S., & McInnes, I. B. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.006 · Cited by 1,301
Self-citationJBS3 Board (2014) · Heart · doi:10.1136/heartjnl-2014-305693 · Cited by 608
Mason, J. C., & Libby, P. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu403 · Cited by 420
IL-6 biology: implications for clinical targeting in rheumatic disease
Calabrese, L. H., & Rose-John, S. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.127 · Cited by 328
Metadata
- Authors
- Robertson, J., Peters, M. J., McInnes, I. B., & Sattar, N.
- Venue
- Nature Reviews Rheumatology
- Published
- 2013-06-18
- Volume
- 9
- Issue
- 9
- Pages
- 513-523
- ISSN
- 1759-4790 (ISSN-L)
- 1759-4804
- OpenAlex
- W2028447671
- Cited by
- 264
- References
- 73
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.